In recent years, it has been found in clinical patients and animal models of MASH that the expression changes in the PPAR involved in mitochondrial fatty acid β-oxidation and regulated by mt-ROS are significantly correlated with the occurrence of MASH. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.